Keywords: Financial results, Nine months 2013, Takeda, Mitsubishi, Ono Pharma, Shionogi
Takeda, Shionogi, Ono Pharma and Mitsubishi Tanabe post nine-month results
Article | 04 February 2013
Takeda Pharmaceuticals (TYO: 4502), Japan’s largest drugmaker, has reported nine-month 2013 results with 5.5% increase in revenues to 1,189.1 billion yen ($12.84 billion); ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
